Replies to post #96446 on Anavex Life Sciences Corp (AVXL)

[stealthways]

Electrical P300 great results... and positive correlation to others...
"The P300 wave amplitude showed a small initial increase from about 6 microvolts to 7 microvolts by four weeks, and then returned to about 6 microvolts until about week 32. Thereafter, it steadily improved to about 8 microvolts by 57 weeks—a level usually seen in healthy age-matched controls. There was a significant separation from the P300 decline seen in a matched historical Alzheimer’s disease cohort, which decreased to about 4 microvolts over a 52-week period while patients were taking donepezil."
Note that a placebo has zero to no benefit in sorting out p300 ....could the FDA look at this and decide avxl only needs a "tiny" placebo for phase 3 (or better even none)... and therefore save even more money in the p3...